These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Properties of cold agglutinin and group carbohydrate-specific antibodies isolated from group C streptococcal antisera. Brown JC, Colling RG. Mol Immunol; 1982 Mar; 19(3):457-65. PubMed ID: 7099171 [Abstract] [Full Text] [Related]
11. Demonstration of opsonic activity and in vivo protection against group B streptococci type III by Streptococcus pneumoniae type 14 antisera. Fischer GW, Lowell GH, Crumrine MH, Bass JW. J Exp Med; 1978 Sep 01; 148(3):776-86. PubMed ID: 29937 [Abstract] [Full Text] [Related]
16. Epitope specificity of rabbit immunoglobulin G (IgG) elicited by pneumococcal type 23F synthetic oligosaccharide- and native polysaccharide-protein conjugate vaccines: comparison with human anti-polysaccharide 23F IgG. Alonso de Velasco E, Verheul AF, van Steijn AM, Dekker HA, Feldman RG, Fernández IM, Kamerling JP, Vliegenthart JF, Verhoef J, Snippe H. Infect Immun; 1994 Mar 01; 62(3):799-808. PubMed ID: 7509318 [Abstract] [Full Text] [Related]
17. Occurrence of 19S and 7S anti-IgGs during hyperimmunization of rabbits with streptococci. Bokisch VA, Bernstein D, Krause RM. J Exp Med; 1972 Oct 01; 136(4):799-815. PubMed ID: 4403474 [Abstract] [Full Text] [Related]
20. Stimulation of protective antibodies against type Ia and Ib group B streptococci by a type Ia polysaccharide-tetanus toxoid conjugate vaccine. Wessels MR, Paoletti LC, Rodewald AK, Michon F, DiFabio J, Jennings HJ, Kasper DL. Infect Immun; 1993 Nov 01; 61(11):4760-6. PubMed ID: 8406875 [Abstract] [Full Text] [Related] Page: [Next] [New Search]